Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-02

Clinical Trial Update: Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating neurotrophic and cholinergic treatment for Alzheimer's disease. The study has completed and results were posted in 2009…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neurotrophic and Cholinergic Treatment (experimental)

Snippet

Sponsor: Ever Neuro Pharma GmbH | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2009-06-02